Scilex Holding (SCLXW) Inventory (2021 - 2026)
Scilex Holding (SCLXW) recorded quarterly Inventory of $4.5 million in Q1 2026, down 5.37% quarter-over-quarter from $4.8 million in Q4 2025, and up 50.22% on a YoY basis from $3.0 million in Q1 2025.
Scilex Holding (SCLXW) Inventory (2021 - 2026) Analysis & Trends
Scilex Holding's Inventory history runs 6 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- In Q1 2026, Inventory rose 50.22% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (up 50.22% YoY), while the FY2025 annual figure was $4.8 million, up 96.59% from the prior year.
- Inventory was $4.5 million for Q1 2026 at Scilex Holding, down from $4.8 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $4.8 million in Q4 2025 to a low of $1.1 million in Q3 2025.
- Historically, Inventory has averaged $3.0 million across 5 years, with a median of $3.0 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Inventory soared 205.81% in 2023, then plunged 54.99% in 2025.
- A 5-year view of Inventory shows it stood at $1.4 million in 2022, then jumped by 205.81% to $4.2 million in 2023, then slumped by 42.19% to $2.4 million in 2024, then jumped by 96.59% to $4.8 million in 2025, then slipped by 5.37% to $4.5 million in 2026.
- The last three Inventory figures came in at $4.5 million (Q1 2026), $4.8 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 8.30 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 14.53 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 14.58 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 5.05 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 6.48 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 6.19 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 1.91 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 10.67 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 2.76 Bn |
| 10 | Scilex Holding | - | - | 4.15 Mn | 4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.53 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Sep 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Sep 30, 2023 | 3.94 Mn |
| Jun 30, 2023 | 3.11 Mn |
| Mar 31, 2023 | 2.28 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 2.56 Mn |